{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:46:58Z","timestamp":1785833218373,"version":"3.56.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7689","type":"journal-article","created":{"date-parts":[[2017,5,14]],"date-time":"2017-05-14T18:11:28Z","timestamp":1494785488000},"page":"1231-1234","source":"Crossref","is-referenced-by-count":22,"title":["Brain Biopsy Is More Reliable than the DNA test for JC Virus in Cerebrospinal Fluid for the Diagnosis of Progressive Multifocal Leukoencephalopathy"],"prefix":"10.2169","volume":"56","author":[{"given":"Junji","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetuya","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Nakamichi","sequence":"additional","affiliation":[{"name":"Division of Virology 1, National Institute of Infectious Diseases, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[{"name":"Division of Virology 1, National Institute of Infectious Diseases, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-ichi","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Weissert R. Progressive multifocal leukoencephalopathy. J Neuroimmunol 231: 73-77, 2011.","DOI":"10.1016\/j.jneuroim.2010.09.021"},{"key":"2","unstructured":"2. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9: 425-437, 2010."},{"key":"3","unstructured":"3. Marshall LJ, Major EO. Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J Neuroimmune Pharmacol 5: 404-417, 2010."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakamichi K, Mizusawa H, Yamada M, et al. Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan. BMC Neurol 12: 121, 2012.","DOI":"10.1186\/1471-2377-12-121"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353: 369-374, 2005.","DOI":"10.1056\/NEJMoa051782"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353: 375-381, 2005.","DOI":"10.1056\/NEJMoa051847"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Richardson EP Jr, Johnson PC. Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates. Acta Neuropathol (Suppl 6): 247-250, 1975.","DOI":"10.1007\/978-3-662-08456-4_43"},{"key":"8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","volume":"18","author":"MA French","year":"2004","unstructured":"8. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 18: 1615-1627, 2004.","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Koralnik IJ, Du Pasquier RA, Letvin NL. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol 75: 3483-3487, 2001.","DOI":"10.1128\/JVI.75.7.3483-3487.2001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kuhle J, Gosert R, B\u00fchler R, et al. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology 77: 2010-2016, 2011.","DOI":"10.1212\/WNL.0b013e31823b9b27"},{"key":"11","unstructured":"11. Landry ML, Eid T, Bannykh S, Major E. False negative PCR despite high levels of JC virus DNA in spinal fluid: implications for diagnostic testing. J Clin Virol 43: 247-249, 2008."},{"key":"12","unstructured":"12. Babi MA, Pendlebury W, Braff S, Waheed W. JC virus PCR detection is not infallible: a fulminant case of progressive multifocal leukoencephalopathy with false-negative cerebrospinal fluid studies despite progressive clinical course and radiological findings. Case Rep Neurol Med 2015: 643216, 2015."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mizusawa H, Kishida S, Saijo M, et al. Progressive multifocal leukoencephalopathy. Clin Neurol 51: 1051-1057, 2011 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.51.1051"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kishi S, Tanaka K. Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med 49: 2509-2513, 2010.","DOI":"10.2169\/internalmedicine.49.3227"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Beppu M, Kawamoto M, Nukuzuma S, Kohara N. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med 51: 1245-1247, 2012.","DOI":"10.2169\/internalmedicine.51.6810"},{"key":"16","unstructured":"16. Togo M, Kawamoto M, Sekiya H, Beppu M, Kohara N. Non HIV-PML patients with favorable outcome using mefloquine: report of two cases. Neurol Med 82: 228-231, 2015 (in Japanese, Abstract in English)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Verma S, Cikurel K, Koralnik IJ, et al. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis 196: 709-711, 2007.","DOI":"10.1086\/520514"},{"key":"18","unstructured":"18. Epperla N, Medina-Flores R, Mazza JJ, Yale SH. Mirtazapine and mefloquine therapy for non-AIDS related progressive multifocal leukoencephalopathy. W M J 113: 242-245, 2014."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Clifford DB, Nath A, Cinque P, et al. A study of mefloquine treatment for progressive multifocal leukoencephalopathy results and exploration of predictors of PML outcomes. J Neurovirol 19: 351-358, 2013.","DOI":"10.1007\/s13365-013-0173-y"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Du Pasquier RA, Clark KW, Smith PS, et al. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol 7: 318-322, 2001.","DOI":"10.1080\/13550280152537175"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Du Pasquier RA, Koralnik IJ. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol 9 (Suppl 1): 25-31, 2003.","DOI":"10.1080\/13550280390195315"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Garrote H, de la Fuente A, Garcia JF. Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia. Exp Hematol Oncol 4: 8-11, 2015.","DOI":"10.1186\/s40164-015-0003-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.7689\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T12:39:26Z","timestamp":1569328766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.7689\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7689","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}